statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that...

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference

This is a Bullish indicator signaling ENOV's price could rise from here. Traders may explore going long the stock or buying call options...

Enovis (ENOV, $62.46) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 27, 2024

Artemis Investment Management LLP trimmed its holdings in shares of Enovis Co. (NYSE:ENOV  Free Report) by 9.4% in the fourth quarter, according to its most recent filing with the Securities...

Enovis Co. (NYSE:ENOV) Shares Sold by Artemis Investment Management LLP

This price move could indicate a change in the trend, and may be a buy signal for investors...

Enovis (ENOV, $60.25) price moved above its 50-day Moving Average on March 21, 2024

This is a Bearish indicator signaling ENOV's price could decline from here. Traders may explore shorting the stock or put options...

Enovis (ENOV, $61.69) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 11, 2024

Envestnet Asset Management Inc. raised its holdings in Enovis Co. (NYSE:ENOV  Free Report) by 134.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned...

Enovis Co. (NYSE:ENOV) Shares Bought by Envestnet Asset Management Inc.

Enovis (NYSE:ENOV  Free Report) had its price objective boosted by Canaccord Genuity Group from $73.00 to $75.00 in a research note issued to investors on Friday morning, Benzinga reports...

Enovis (NYSE:ENOV) PT Raised to $75.00

Enovis (NYSE:ENOV  Free Report) had its price target upped by Needham  Company LLC from $73.00 to $82.00 in a report released on Friday, Benzinga reports. They currently have a buy rating...

Needham & Company LLC Boosts Enovis (NYSE:ENOV) Price Target to $82.00

Needham sees orthopedics market slowing; favors Enovis, Paragon 28...

Needham sees orthopedics market slowing; favors Enovis, Paragon 28

This is a signal that ENOV's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Enovis (ENOV, $62.85) RSI Indicator left the overbought zone on February 23, 2024

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Volume	154,800.00
52-Wk High	$66.14
52-Wk Low	$43.04

ENOV Enovis Corp

About

Feed

News

Sentiment

Earnings

Fundamentals